Abstract
“Despite the recession, fundamental drivers for the generic industry are
sound.”
The operating environment for generic companies is changing rapidly as the
industry matures and growth focuses on new market opportunities.
The current economic downturn has impacted the sector in terms of the number
and types of deals but consolidation continues to affect the market, with
fewer big players dominating.
Acquisition is still a favoured route to fast market access but strategic
partnering is on the rise. In such a market you need to know...
But...
- Who are the medium-sized companies of note?
- How well do they perform?
- What drugs do they produce?
- Where are they located?
This report will tell you!
Unbeatable coverage
For each company, where available or appropriate, the report provides...
BACKGROUND
A summary of the company' s foundation and main business interests
PRODUCT RANGE
Details of ANDAs approved or products represented
FINANCIAL
Financial performance or funding data
STRATEGIC ALLIANCES
Details of significant marketing and supply agreements
CONTACT INFORMATION
Use this report to...
- Identify commercial partners
- Understand the developing generic industry in key markets worldwide
- Profile the competitive environment in the increasingly important
medium-sized company sector
- Seek out companies manufacturing/marketing similar product lines
- Assess the investment potential of these developing companies
| 
View Cart
